16 reports

  • OVERVIEW
  • GLOBAL TB DIAGNOSTICS MARKET: SEGMENTATION BY PRODUCT TYPE 2016 (% SHARE)
  • Tuberculosis
  • Forecast
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.

Global R& D spending on Tuberculosis ##. ##.

  • Pathology
  • Tuberculosis
  • World

LACK OF AWARENESS ABOUT TUBERCULOSIS ##. ##.

  • Pathology
  • Tuberculosis
  • World
  • Market Size
  • JAN 11, 2017: SCIENTISTS IDENTIFY PROTEIN CENTRAL TO IMMUNE RESPONSE AGAINST TUBERCULOSIS BACTERIA
  • AUG 02, 2016: STUDY FINDS INNATE IMMUNITY CONNECTION TO RARE, FATAL CHILDHOOD DISEASE, AND POSSIBLY TB
  • Cancer
  • HIV AIDS
  • Specialty Hospital
  • Tuberculosis
  • GlobalData's company
  • TUBERCULOSIS VACCINE
  • TUBERCULOSIS VACCINE - DRUG PROFILE
  • Research And Development
  • Tuberculosis
  • World
  • Product Initiative
  • TB Drug Development, Inc.
  • AERAS ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH TIANJIN CANSINO FOR TUBERCULOSIS VACCINE
  • AERAS ENTERS INTO R&D AGREEMENT WITH GLAXOSMITHKLINE VACCINES TO DEVELOP TUBERCULOSIS VACCINE
  • Tuberculosis
  • Vaccine
  • World
  • Company Operations
  • GlobalData's company
  • 6.3.4 Tuberculosis
  • 4.5.1 Tuberculosis
  • Anti-Infective
  • Infectious Disease
  • Tuberculosis
  • World
  • Deals & Alliance
  • Small Molecule to Inhibit F0F1-ATP Synthase for Tuberculosis
  • Jun 06, 2016: Speeding up drug discovery to fight tuberculosis
  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • Lycera Corp.
  • SMALL MOLECULES TO INHIBIT DNA GYRB FOR TUBERCULOSIS
  • PIPELINE BY ASTRAZENECA PLC, H2 2017
  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • Spero Therapeutics, LLC
  • EPISTEM HOLDINGS ENTERS INTO CO-MARKETING AGREEMENT WITH XCELRIS LABS FOR MOLECULAR TUBERCULOSIS DIAGNOSTIC TEST
  • EPISTEM ENTERS INTO DISTRIBUTION AGREEMENT WITH BECTON DICKINSON FOR MYCOBACTERIUM TB TEST
  • Hepatitis
  • Tuberculosis
  • United Kingdom
  • Company
  • GlobalData's company
  • SANOFI ENTERS INTO RESEARCH AGREEMENT WITH TB ALLIANCE TO ADVANCE TREATMENTS FOR TUBERCULOSIS
  • NOVARTIS ENTERS INTO LICENSING AGREEMENT WITH GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT FOR TUBERCULOSIS DRUGS
  • Pathology
  • Pharmaceutical
  • Tuberculosis
  • World
  • TB Drug Development, Inc.
  • TB ID/R Blood Test - Product Description
  • Infectious Disease
  • Pathology
  • Tuberculosis
  • United States
  • GlobalData's company
  • Infectex Enters Into Licensing Agreement With Qurient For Tuberculosis Drug Q203
  • Qurient Raises USD25.7 Million in IPO
  • Healthcare
  • Tuberculosis
  • South Korea
  • Company
  • Qurient Co., Ltd.
  • Aeras Enters Into Co-Development Agreement With China National Biotech Group
  • PARTNERSHIPS

Aeras Global TB Vaccine Foundation Inc(Aeras) is a nonprofit biotechnology organization that develops tuberculosis (TB) vaccines.

  • Pathology
  • Tuberculosis
  • China
  • Corporate Finance
  • GlobalData's company
  • Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics
  • Oct 06, 2017: FDA awards 15 grants for clinical trials to stimulate product development for rare diseases

In addition, one study evaluates a new combination of existing antibiotics to treat pulmonary tuberculosis (TB), including multidrug-resistant TB.

  • Cancer
  • Pharmaceutical
  • Tuberculosis
  • United States
  • GlobalData's company
  • JANSSEN PHARMA ENTERS INTO AGREEMENT WITH FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS
  • PARTNERSHIPS

The agreement enables FIND, Cepheid and Rutgers to develop next-generation test for mycobacterium tuberculosis.

  • Diagnostics
  • Pharmaceutical
  • Tuberculosis
  • United States
  • GlobalData's company